<p>In the picture, precursor cells of fly wing tissue, labelled for various proteins. This fly model has been used to perform experiments addressing the relationship between chromosome instability, aneuploidy, and tumorigenesis (Lara Barrio, IRB Barcelona)</p>
9 Feb 2016

A recent analysis of 43,205 human tumours unveiled that 68% of solid tumours are aneuploid, that is to say, they have an altered number of chromosomes.

<p>The compound Cp28 (orange) binds to the EGF protein (green), a target in cancer. This interaction prevents EGF from binding to its receptor EGFR.</p>
3 Feb 2016

Advances in new treatments for diseases, including cancer, come about from innovative research with therapeutic potential.

2 Feb 2016

This morning in Madrid, Joan Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona), has been presented with a second

<p>David Vilchez, winner of the "IRB Barcelona Alumni Award of Excellence" (M.Minocri, IRB Barcelona)</p>
29 Jan 2016

Today, IRB Barcelona has presented David Vilchez (Mataró, Barcelona, 1978), group leader at the CECAD-Cluster of Excellence in Cologne (Germany), with the 2016

Investor working

Media mentions

05 Feb 2016

IRB Barcelona synthesizes molecules with anti-tumor potential

El Médico Hospitalario

The medical portal ""El Médico Hospitaliario" and other media report on IRB Barcelona's research on compounds able to act against EGF, a little-explor

02 Feb 2016

Spanish research centres demand recognition of scientific excellence


EFE and Europa Press have reported on the presentation of the Severo Ochoa Awards of Excellence held in Madrid. The director of IRB Barcelona, Joan J. Guinovart, attended the ceremony, along with representatives of other awarded research centres.

01 Feb 2016

“Changing for the first time how we treat metastasis"

El Pais

El Paí has dedicated an article to the new initiative promoting science at IRB Barcelona called "Meet our Scientists," a series of videos that aims to bring scientists to the

Photo gallery


<p>Sonia Armengou</p>
Sònia Armengou
Media Relations Officer
Tel: +34 93 40 37255

Quick facts about IRB

Quick facts

IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.